top of page
Grey Round Patterns
El logotipo de Sherringford

Sherringford

  • Novartis Invests Heavily Against Inflammation in Heart Disease

    Novartis acquires Tourmaline Bio for $1.4 billion, focusing on pacibekitug, a drug that combats inflammation in heart disease like ASCVD, promising significant advancements in cardiovascular treatment.

  • Comentarios
    Comparte lo que piensasSé el primero en escribir un comentario.
bottom of page